Group 6 Copy 103
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Where are the Pacific harbor seals in Mexico?

    Pacific Harbor seals use land to give birth to pups and molt, but once they return to the ocean to forage many...

    Azolla, a little fern with massive green potential

    Azolla is a symbiotic superorganism that captures all the nitrogen fertilizer it needs to grow from the air...

    Backer Badge Funded

    A biology project funded by 47 people